ATE381343T1 - Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion - Google Patents

Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion

Info

Publication number
ATE381343T1
ATE381343T1 AT00972638T AT00972638T ATE381343T1 AT E381343 T1 ATE381343 T1 AT E381343T1 AT 00972638 T AT00972638 T AT 00972638T AT 00972638 T AT00972638 T AT 00972638T AT E381343 T1 ATE381343 T1 AT E381343T1
Authority
AT
Austria
Prior art keywords
agent
appetite suppression
saturation induction
growth hormone
promotes
Prior art date
Application number
AT00972638T
Other languages
English (en)
Inventor
Kjell Malmloef
Hanne Jepsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE381343T1 publication Critical patent/ATE381343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT00972638T 1999-11-03 2000-10-27 Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion ATE381343T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199901585 1999-11-03

Publications (1)

Publication Number Publication Date
ATE381343T1 true ATE381343T1 (de) 2008-01-15

Family

ID=8106297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00972638T ATE381343T1 (de) 1999-11-03 2000-10-27 Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion

Country Status (7)

Country Link
US (2) US20030105005A1 (de)
EP (1) EP1229927B1 (de)
JP (1) JP2003534237A (de)
AT (1) ATE381343T1 (de)
AU (1) AU1130501A (de)
DE (1) DE60037535D1 (de)
WO (1) WO2001032200A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248788A1 (en) * 2001-07-06 2004-12-09 Vickers Mark Hedley Hypertenson treatment
EP2277910A1 (de) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin Fusionsproteine
CA2496687A1 (en) * 2002-09-18 2004-04-01 Centre Hospitalier De L'universite De Montreal (Chum) Ghrh analogues

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856942A (en) * 1973-05-10 1974-12-24 P Murphy Appetite control composition
US4863901A (en) * 1986-01-09 1989-09-05 Brigham & Women's Hospital Use of growth hormone for nitrogen retention under hypocaloric conditions
EP0363063A3 (de) * 1988-09-29 1990-07-25 Bunge (Australia) Proprietary Limited Schafwachstumshormon
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
US5912229A (en) * 1996-03-01 1999-06-15 Novo Nordisk Als Use of a pharmaceutical composition comprising an appetite-suppressing peptide
SE9601397D0 (sv) * 1996-04-12 1996-04-12 Pharmacia Ab Use of growth hormone
US5652301A (en) * 1996-08-20 1997-07-29 Bayer Corporation Aqueous polyurea dispersions and their use for preparing coatings with excellent hydrolytic and thermal stability
US6458924B2 (en) * 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
DE69732572T2 (de) * 1996-11-12 2005-12-29 Novo Nordisk A/S Verwendung von glp-1 peptiden
US5952301A (en) * 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function
US6051557A (en) * 1997-05-16 2000-04-18 1149336 Ontario Inc. Methods of enhancing functioning of the upper gastrointestinal tract
AU756797B2 (en) * 1998-11-10 2003-01-23 Banyu Pharmaceutical Co., Ltd. Spiro-indolines as Y5 receptor antagonists

Also Published As

Publication number Publication date
WO2001032200A1 (en) 2001-05-10
JP2003534237A (ja) 2003-11-18
US20050171003A1 (en) 2005-08-04
EP1229927B1 (de) 2007-12-19
US20030105005A1 (en) 2003-06-05
EP1229927A1 (de) 2002-08-14
AU1130501A (en) 2001-05-14
DE60037535D1 (de) 2008-01-31

Similar Documents

Publication Publication Date Title
DE50207513D1 (de) Inkontinenzband zur behandlung der harninkontinenz
GB2417206B (en) Method for the automatic plotting of pressure-volume curves during artificial respiration
ATE358462T1 (de) Vorrichtung zur befestigung von weichgewebe an einer kunstprothese
DE69709535D1 (de) Orthopädische Vorrichtung zur allmählichen Korrektur von Gliedern
ATE302181T1 (de) Verbindungen zur stimulation der sekretion von wachstumshormonen
DE60217176D1 (de) Mehrflügeliger ballonkatheter zur verminderung von schäden an beschichteten expandierbaren medizinischen implantaten
ATE523221T1 (de) Systeme und verfahren für die bilaterale stimulierung von linken und rechten ästen der dorsalen genitalnerven zur behandlung von funktionsstörungen, wie z.b. harninkontinenz
DE60126019D1 (de) Vorrichtung zur patientenspezifischen Anpassung einer Hornhautkorrektur
AU6459000A (en) Method and apparatus for delivering cement to bones and/or positioning components
AU7574601A (en) Tissue implant
ATE361107T1 (de) Verfahren zur beschichtung von implantaten mittels eines druckverfahrens
DE69943380D1 (de) Verfahren und vorrichtung zur verzerrungskompensation eines funkgerätes
DE60318052D1 (de) Implantierbare prothese
ATE381343T1 (de) Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion
DK1119393T3 (da) Elektromagnetisk stimulering af bruskvæv ved anvendelse af FGF
GB2348138B (en) Method and apparatus for positioning tracheal/bronchial endoprostheses
PL356364A1 (en) Application of growth hormone secretion stimulating compound and a set therefor
AR021286A1 (es) Un metodo de tratamiento de tumores en mamiferos mediante la administracion de compuestos que inducen la liberacion de la hormona del crecimiento y susantagonistas
DK1420836T3 (da) Forbindelsesindretning for en implanterbar port og et portsystem, der omfatter forbindelseindretningen
ATE543470T1 (de) Schiene oder stütze mit schneller lokalisierungstechnik
DE60328859D1 (de) Bildverarbeitungsvorrichtung und Verfahren zur Konstrastverstärkung mittels Histogrammausgleich
DE50001023D1 (de) Verfahren und schaltungsanordnung zur kontrastverbesserung eines bildes
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
DE60127810D1 (de) Zeithaltendes Gerät mit automatischer Zeitkorrektur und Verfahren zur Zeitkorrektur eines derartigen Gerätes
DK1189627T3 (da) Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties